Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
ARVEE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arvee Laboratories reported its Q1 FY26 (quarter ended June 30, 2025) results. Revenue from operations fell to ₹748 lakhs from ₹1,060.22 lakhs in the same quarter last year, a decline of about 29%. Profit after tax dropped sharply to ₹16.91 lakhs from ₹94.21 lakhs, down roughly 82% year-on-year, with EPS of ₹0.15 versus ₹0.85 previously. Total expenses were lower at ₹747.45 lakhs, helped by a fall in cost of materials consumed. The auditor (Nirav Patel & Associates) issued a clean limited review report with no qualifications. The board also approved the appointment of Mr. Saurin Ajitbhai Gandhi (current CFO) as an Additional Director and fixed September 24, 2025 as the AGM date.
Sharp year-on-year falls in both revenue and profit point to weak quarterly performance, which may weigh on short-term investor sentiment. However, results remain profitable and the auditor's report is clean, with no red flags raised.